
USFDA16 Nov 2026, 02:14 pm
Wanbury Tanuku Plant US FDA Inspection: Official Action Indicated
AI Summary
Wanbury Limited has received communication from the US FDA regarding the inspection of its Tanuku API manufacturing facility. The inspection, conducted from July 13-17, 2026, has been classified as 'Official Action Indicated' (OAI). The company stated that this classification is not expected to impact business continuity or customer supplies from the facility. Wanbury is committed to working with the US FDA and maintaining high standards of quality and compliance.
Key Highlights
- Tanuku plant inspection classified as 'Official Action Indicated' (OAI).
- No expected impact on business continuity or customer supplies.
- Company committed to working with US FDA.
- Maintaining high standards of quality and compliance.
Price Impact
More from WANBURY